Efficacy of Infliximab on the acute attack of uveitis

Authors

• Fahdah Alokaily, Department of Medicine, Division of Rheumatology, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia.
• Sulaiman Alsaleh, Department of Medicine, Division of Rheumatology, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia.
• Maryseon Al-Balawi, Department of Medicine, Division of Rheumatology, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia.
• Seham Al-Rashidi, Department of Medicine, Division of Rheumatology, Riyadh Military Hospital, PO Box 7897, Riyadh 11159, Kingdom of Saudi Arabia.

Abstract

Uveitis is one of the major features of behcet9s disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet9s uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.

Article Type

Case Report

First Page

82

Last Page

85

Recommended Citation

Alokaily, Fahdah; Alsaleh, Sulaiman; Al-Balawi, Maryseon; and Al-Rashidi, Seham (2010) "Efficacy of Infliximab on the acute attack of uveitis," Saudi Medical Journal: Vol. 31: Iss. 1, Article 17.
DOI: https://doi.org/10.15537/1658-3175.4938